LPCN compared with ZNTL: revenue, margins and what each company keeps, and the suppliers and customers both name

LPCNLipocine Inc.

Mkt capRevenueRevenue

ZNTLZentalis Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

LPCNLipocine Inc.

ZNTLZentalis Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LPCN 0

None

Shared 0

No disclosed counterparties: LPCN.

Only ZNTL 5

PFEPfizersupplier

IMNMImmunomecustomer

GSKGSKsupplier

—Dana‑Farber Cancer Instituteunlistedsupplier

1 more · ZNTL chain ›

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

LPCNLipocine Inc.

1.58▲+3.56%· post 1.55

Mkt cap$17.4MRevenue$2MQ3 FY26Revenue$2MFY25

ZNTLZentalis Pharmaceuticals, Inc.

1.73▲+1.17%· post 1.73

ClosedNov 6 '26

Mkt cap$122.6MRevenue$27MQ4 FY24Revenue—

Compare

ClosedNov 6 '26

LPCNLipocine Inc.

ZNTLZentalis Pharmaceuticals, Inc.

1.58▲+3.56%post 1.55

Price

1.73▲+1.17%post 1.73

$17.4M

Mkt cap

$122.6M

Q3 FY26$2M

Revenue

$27MQ4 FY24

FY25$2M

Revenue

—

LPCN1.58▲+3.56%vsZNTL1.73▲+1.17%ClosedNov 6 '26